The Pfizer Clinical Research Unit in New Haven is seeking healthy volunteers for a COVID-19 clinical trial that will look at the effects of the study drug alone and when combined with an additional medication.
COVID-19 is the illness resulting from the novel coronavirus SARS-CoV-2. Millions of people worldwide have been impacted by this illness.
Despite efforts to vaccinate against the virus, treatments are still needed for those who become ill to aid in their recovery. Read more about this study below and see how you can make a difference as a healthy volunteer.
Who may participate
All new medicines and vaccines are first tested in clinical trials with healthy volunteers. When you choose to participate, you become an essential part of future medical discoveries.
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- Willing and able to comply with all study procedures
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Condition
Healthy
Age
18+ years
Sex
All sexes
Referral bonus
Up to $200
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
Who may participate
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will stay at our facility for 18 consecutive overnights. The morning after admission, you will receive a single dose of the study drug. About 2 days later, you will begin receiving daily doses of an additional medication in a titration (meaning the dose will slowly increase) for a total of 15 days. On the 14th morning of dosing with this medication, you will also receive another dose of the study drug.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood, urine, and stool.
Required overnight stays
18
Long-term follow up
1 phone call
How long is this study?
About 46 days
Compensation
Up to $8,200 upon completion of the study
All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.